Innovation1 Biotech Inc (IVBT)
Innovation1 Biotech Inc. is a healthcare company listed on OTC Markets under the ticker IVBT. The company is focused on researching, developing, producing, and selling pharmaceutical products. Its current product set includes natural supplements marketed for symptoms associated with flu and long COVID, sold under the NutraFlu and Nutravid19 brands, along with other supplement and medical nutrition products. Innovation1 Biotech is also advancing NLC001, which is in Phase II clinical testing for long COVID and other viral indications. The company is based in New York, New York.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-IVBT
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
January 15, 2027
|
4.494 K
|
